<![CDATA[Sungening Biological Co., Ltd.]]> zh_CN 2026-06-04 16:26:51 2026-06-04 16:26:51 YBlog RSS Generator 5 <![CDATA[产品名称]]> <![CDATA[产品名称]]> <![CDATA[产品名称]]> <![CDATA[产品名称]]> <![CDATA[产品名称]]> <![CDATA[产品名称]]> <![CDATA[产品名称]]> <![CDATA[Scenario Application and Insights of AI in Clinical Trials | AI in Clinical Trials]]> <![CDATA[Cyclic Peptides: Leading the Future Innovation and R&D of Peptide Drugs]]> <![CDATA[New Blue Ocean in Pharmaceuticals: Why Are Industry Giants Betting Big on Oral Cyclopeptides?]]> <![CDATA[Oral Macrocyclic Peptides Are Gaining Quiet Momentum]]> <![CDATA[Cyclic peptide RDC is gaining favor among MNCs.]]> <![CDATA[Merck Strikes New Partnership, Betting on AI for the Next Drug Discovery Wave]]> <![CDATA[Cyclic Peptides: Ultimate Beneficiaries of Technological Iteration and Disruptors of the Market Landscape]]> <![CDATA[Clinical Application and Research Progress of PCSK9 Inhibitors in Ischemic Stroke Complicated with Dyslipidemia]]> <![CDATA[Sungening Won the First Prize in the Industry Final (Biomedicine) of the 16th China Shenzhen Innovation and Entrepreneurship Competition Longgang Division Qualifier & the 4th Longgang Innovation and Entrepreneurship Star Competition!]]> <![CDATA[2025 J.P. Morgan Week | Sungening Innovative Project to Debut in San Francisco]]> <![CDATA[Corporate Milestone | Potential FIC Candidate! Sungening’s Class 1 Antifungal New Drug SG1001 Completes Phase I Clinical Trial]]> <![CDATA[【Company Announcement】The oral cyclic peptide innovative drug project SG6001 of Sungening has been included in the Support Program for Strategic Emerging Industries of Shenzhen (Special Project for Core Technology Research Breakthroughs)]]> <![CDATA[Longgang Financial Holdings Investment News | Longgang Guidance Fund Completes Investment in Local Innovative Drug Enterprise Sungening]]> <![CDATA[【Company Announcement】Sungening Honored as National High-Tech Enterprise!]]> <![CDATA[Corporate Milestone | Sungening and Livzon Pharmaceutical Announce: First Patient Dosed in Phase II Clinical Trial of Class 1 Novel Antifungal Drug SG1001]]> <![CDATA[Corporate Announcement | Sungening Named One of Longgang District Top 100 Emerging Enterprises, Innovative Strength Authoritatively Recognized!]]> <![CDATA[Corporate Milestone | Breaking News! Sungening’s Innovative Drug SG1001 Secures FDA Clinical Trial Approval, Embarking on Its Global Journey!]]>